Oramed Pharmaceuticals Inc. (ORMP) ownership: Top institutional holder: BML Capital Management, LLC ($10.77M). Insider activity: Net Seller (2 buys, 5 sells). 4 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BML Capital Management, LLC | 3167231.00 | $10.77M | 2026-03-31 |
| Aquamarine Financial (Cayman) Ltd | 2112312.00 | $7.18M | 2026-03-31 |
| MERCER GLOBAL ADVISORS INC /ADV | 1910540.00 | $6.50M | 2026-03-31 |
| Gem Investment Advisors, LLC | 1640069.00 | $5.58M | 2026-03-31 |
| SB Capital Management Inc | 1900000.00 | $5.42M | 2025-12-31 |
| Murchinson Ltd. | 1315294.00 | $4.47M | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 600716.00 | $2.04M | 2026-03-31 |
| MARSHALL WACE, LLP | 259611.00 | $882677.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-03-30 | |
| Buy | null | 2026-03-30 | |
| Sell | null | 2026-03-17 | |
| Sell | null | 2026-03-17 | |
| Sell | null | 2026-03-17 | |
| Sell | null | 2026-03-17 | |
| Sell | null | 2026-03-12 |
Back to ORMP overview · ORMP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.